A Comparative Study between Dexmedetomidine versus Fentanyl to Facilitate Awake Fibreoptic Nasal Intubation under General Anaesthesia
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.129 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Tanya Jain und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Awake fibreoptic nasal intubation (AFOI) is the gold standard for managing anticipated difficult airways. Achieving optimal sedation without compromising respiratory function and hemodynamic stability remains a clinical challenge.
Aim
To compare the efficacy and safety of dexmedetomidine versus fentanyl in facilitating awake fibreoptic nasal intubation.
Methods
This prospective, randomized, double-blind comparative study included 50 patients (ASA physical status I–II) aged 20–50 years undergoing elective surgery requiring AFOI. Patients were randomly allocated into two groups: Group D received dexmedetomidine (1 µg/kg), and Group F received fentanyl (2 µg/kg), both administered as intravenous infusion over 10 minutes. Sedation was assessed using the Ramsay Sedation Score (RSS). Intubation conditions were evaluated using cough score and post-intubation tolerance score. Hemodynamic parameters and oxygen saturation were recorded. Statistical analysis was performed using SPSS version 27, with p < 0.05 considered significant.
Results
Dexmedetomidine provided significantly better sedation with higher proportion of patients achieving optimal RSS scores (p = 0.03). Intubation conditions were superior in Group D, with reduced cough response (p = 0.01) and improved post-intubation tolerance (p = 0.02). Hemodynamic stability was better maintained with dexmedetomidine, showing minimal changes in heart rate and mean arterial pressure compared to fentanyl (p < 0.01). The incidence of oxygen desaturation was significantly lower in Group D (4%) than Group F (28%) (p = 0.02). First-attempt intubation success was higher and intubation time shorter in the dexmedetomidine group.
Conclusion
Dexmedetomidine is superior to fentanyl for awake fibreoptic nasal intubation, providing better sedation, improved intubation conditions, enhanced hemodynamic stability, and reduced respiratory complications. It can be considered the preferred sedative agent for AFOI in patients with anticipated difficult airway.
Zitieren
APA
Jain, T., Chakrawarty, D., & Sushma, S. (2026). A Comparative Study between Dexmedetomidine versus Fentanyl to Facilitate Awake Fibreoptic Nasal Intubation under General Anaesthesia. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.129
Vancouver
Jain T, Chakrawarty D, Sushma S. A Comparative Study between Dexmedetomidine versus Fentanyl to Facilitate Awake Fibreoptic Nasal Intubation under General Anaesthesia. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.129
BibTeX
@article{Jain2026,
author = {Jain, Tanya and Chakrawarty, Devashish and Sushma, Sushma},
title = {A Comparative Study between Dexmedetomidine versus Fentanyl to Facilitate Awake Fibreoptic Nasal Intubation under General Anaesthesia},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.129}
}
EUVIMED